# NAPROXEN SODIUM
> **ANDA215472** · Abbreviated New Drug Application (Generic) · Sponsor: ONESOURCE SPECIALTY · Approved 2022-08-17
## Drug
- **FDA Application Number:** ANDA215472
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NAPROXEN SODIUM
- **Generic name:** Naproxen Sodium
- **Active ingredients:** NAPROXEN SODIUM
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** ONESOURCE SPECIALTY
- **First approval:** 2022-08-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215472)
---
*MORVS · CC0 1.0*